In-depth guides to specific peptides
Research summaries, U.S. legal status, safety considerations, and what is still unknown — one peptide at a time.
- Peptide GuideUpdated May 30, 2026
Epitalon Guide: Research, Safety, and U.S. Legal Context
A research-focused overview of Epitalon, including AEDG biology, telomerase and pineal research, safety limits, and U.S. regulatory context.
Read - Peptide GuideUpdated May 29, 2026
Semax Peptide Guide: Research, Safety, and U.S. Legal Context
A research-focused overview of Semax, including ACTH fragment biology, neurologic research, intranasal delivery questions, safety limits, and U.S. regulatory context.
Read - Peptide GuideUpdated May 27, 2026
DSIP Peptide Guide: Emideltide Research, Safety, and U.S. Context
A research-focused overview of DSIP, also called Emideltide, including sleep-related evidence, safety uncertainty, and U.S. compounding context.
Read - Peptide GuideUpdated May 26, 2026
MOTS-c Guide: Research, Safety, and U.S. Legal Context
A research-focused overview of MOTS-c, including mitochondrial-derived peptide biology, metabolic research, safety limits, and U.S. regulatory context.
Read - Peptide GuideUpdated May 24, 2026
TB-500 Guide: Research, Safety, and U.S. Legal Context
A research-focused overview of TB-500, including thymosin beta-4 biology, evidence limits, athlete restrictions, and U.S. regulatory context.
Read - Peptide GuideUpdated May 23, 2026
KPV Peptide Guide: Research, Safety, and U.S. Legal Context
A research-focused overview of KPV, including what the peptide is, why researchers study it, where evidence remains limited, and how U.S. rules may affect future access.
Read - Peptide GuideUpdated May 13, 2026
Dihexa Acetate Guide: Research, Safety & U.S. Context
A cautious educational overview of Dihexa acetate research and what remains uncertain in human evidence.
Read - Peptide GuideUpdated May 13, 2026
GHK-Cu Guide: Research, Safety & U.S. Context
A research-focused overview of GHK-Cu and how evidence, safety, and access questions are typically evaluated.
Read - Peptide GuideUpdated May 13, 2026
LL-37 Guide: Research, Safety & U.S. Context
A research-focused overview of LL-37 and how clinicians and patients should interpret early evidence.
Read - Peptide GuideUpdated May 13, 2026
Melanotan II Guide: Research, Safety & U.S. Context
Educational context on Melanotan II, emphasizing evidence limits, safety questions, and lawful access pathways.
Read - Peptide GuideUpdated May 13, 2026
PEG-MGF Guide: Research, Safety & U.S. Context
What PEG-MGF is in research discussions, and how evidence and access questions are typically evaluated.
Read - Peptide GuideUpdated May 12, 2026
BPC-157 Guide: Research, Legal Status, Safety & U.S. Updates
A plain-English guide to BPC-157 — what early research suggests, its U.S. legal status, safety considerations, and what may change next.
Read
Be notified when eligible access pathways open.
Join the MedTideUSA waitlist for portfolio updates, regulatory context, and early notification when compliant peptide access becomes available.
MedTideUSA is currently informational only. Future services, if available, will be subject to applicable law, clinician review, and safety protocols.